Imbalance of placental regulatory T cell and Th17 cell population dynamics in the FIV-infected pregnant cat by Crystal E Boudreaux et al.
Boudreaux et al. Virology Journal 2012, 1:88
http://www.virologyj.com/content/1/9/88RESEARCH Open AccessImbalance of placental regulatory T cell and Th17
cell population dynamics in the FIV-infected
pregnant cat
Crystal E Boudreaux, Lyndon B Chumbley, Veronica L Scott, Dwayne A Wise and Karen S Coats*Abstract
Background: An appropriate balance in placental regulatory T cells (Tregs), an immunosuppressive cell population,
and Th17 cells, a pro-inflammatory cell population, is essential in allowing tolerance of the semi-allogeneic fetus.
TGF-β and IL-6 are cytokines that promote differentiation of Tregs and Th17 cells from a common progenitor;
aberrant expression of the cytokines may perturb the balance in the two cell populations. We previously reported a
pro-inflammatory placental environment with decreased levels of FoxP3, a Treg marker, and increased levels of IL-6
in the placentas of FIV-infected cats at early pregnancy. Thus, we hypothesized that FIV infection in the pregnant
cat causes altered placental Treg and Th17 cell populations, possibly resulting in placental inflammation.
Methods: We examined the effect of FIV infection on Treg and Th17 populations in placentas at early pregnancy
using quantitative confocal microscopy to measure FoxP3 or RORγ, a Th17 marker, and qPCR to quantify expression
of the key cytokines TGF-β and IL-6.
Results: FoxP3 and RORγ were positively correlated in FIV-infected placentas at early pregnancy, but not placentas
from normal cats, indicating virus-induced alteration in the balance of these cell populations. In control cats the
expression of IL-6 and RORγ was positively correlated as predicted, but this relationship was disrupted in infected
animals. TGF-β was reduced in infected queens, an occurrence that could dysregulate both Treg and Th17 cell
populations. Co-expression analyses revealed a highly significant positive correlation between IL-6 and TGF-β
expression in control animals that did not occur in infected animals.
Conclusion: Collectively, these data point toward potential disruption in the balance of Treg and Th17 cell
populations that may contribute to FIV-induced inflammation in the feline placenta.
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Maternal tolerance of the semi-allogeneic fetus is accom-
plished, in part, by the expression of cytokines and other
immunoregulatory molecules at the maternal-fetal inter-
face which modulate appropriate placental immunology
[1,2]. The Th1/Th2 paradigm, which assumed that Th2
(anti-inflammatory) cytokines dominate the maternal-fetal
interface during most of pregnancy while Th1 (pro-
inflammatory) cytokines are suppressed until the ap-
proach of parturition [3], has been recently succeeded by
a Th1/Th2/Th17 and regulatory T cell paradigm [4] that* Correspondence: kcoats@grad.msstate.edu
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distribution, and reproduction in any mediumallows for a cytokine milieu during various stages of preg-
nancy which does not fit the traditional Th1/Th2 model.
Clearly, placental immunology is highly complex and tem-
poral, coincident with changes in cell populations and
immunomodulation as pregnancy progresses from im-
plantation to onset of labor (reviewed in [5]).
Tregs and Th17 cells differentiate from a common T
helper progenitor cell. TGF-β causes the proliferation of
both Treg and Th17 cells [6,7]. During inflammation,
enhanced production of IL-6 inhibits the induction of
FoxP3, halting the generation of Tregs, and activates the
expression of RORγ, driving the proliferation of Th17
cells [8]. Th17 cells further enhance the inflammatory re-
sponse by releasing the cytokines IL17, IL-6, TNFα, andtral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tory cellular response and an inverse relationship be-
tween Tregs and Th17 cells [8]. Disruption in cytokine
expression potentially perturbs the balance in the two
cell populations.
Several investigators have correlated increased num-
bers of activated Treg cells in the periphery and decidua
with successful pregnancies, while a reduced number of
Tregs accompany failed pregnancies [9-11]. The inflam-
matory cytokine IL-17, a product of Th17 cells, was
found to localize in cytotrophoblast and syncytiotropho-
blast cells in the deciduas of unexplained recurrent spon-
taneous abortions (URSA) and normal early pregnant
women, but IL-17 was significantly higher in the URSA
group [12]. This finding suggests that Th17 cells may
play a role in pregnancy failure.
The complexity of placental immunology confounds
the ability to define the causal relationship between ab-
errant placental immunology and perturbed pregnancy.
Importantly, HIV infection in pregnant women has
been associated with increased reproductive failure
[13,14], and there is evidence that the virus alters pla-
cental cytokine expression, promoting mother-to-child
transmission [15]. The need for additional study is ap-
parent; yet, the inability to obtain human tissues at will
to conduct these investigations highlights the value of
an animal model.
We use the FIV-infected cat model to evaluate para-
meters of lentivirus-induced placental inflammation. Our
previous data suggest a pro-inflammatory placental
microenvironment at early pregnancy in the infected cat,
based on the ratio of pro- to anti-inflammatory cyto-
kines, expression of IL-6 [16], and the likely decreased
population of Tregs [17]. In the present study we
hypothesized that FIV infection in the pregnant cat
causes altered placental Treg and Th17 cell population
dynamics, allowing placental inflammation that may
compromise pregnancy. Placental immunology is dis-
tinctly different at early and late stages of pregnancy;
therefore, it was important to evaluate the impact of FIV
infection in the feline placenta at these two time points.
Our first objective was to localize the two cell popula-
tions by labeling parallel sections with either FoxP3 or
RORγ-specific antibody and comparing both to a parallel
specimen immunolabeled with anti-relaxin antibody. As
relaxin is produced by trophoblasts, its presence demar-
cates the maternal-fetal interface. The two cell popula-
tions were localized to this region. Our second objective
was to quantify the expression of Treg marker FoxP3
and Th17 marker RORγ in placental samples from FIV-
infected and control queens at early gestation by im-
munofluorescence confocal microscopy. FoxP3 expres-
sion was significantly reduced in infected tissues while
RORγ expression was unaffected. FoxP3 and RORγ werepositively correlated in FIV-infected placentas, while in
control placentas no correlation occurred. The third ob-
jective was to evaluate expression of the key cytokines
that drive Treg and Th17 proliferation, TGF-β and IL-6.
TGF-β was significantly reduced, and the normal posi-
tive correlation in co-expression between the two cyto-
kines was disrupted in infected tissues. Finally, we
correlated expression of IL-6 with RORγ. As an
enhanced level of IL-6 is indicative of inflammation, its
expression should be inversely correlated to Treg func-
tion and positively correlated with Th17 function. In
control cats the expression of IL-6 and RORγ was posi-
tively correlated as predicted, but this relationship was
disrupted in infected animals. Collectively, the data sug-
gest that FIV-induced immunopathology may include
perturbation of Treg/Th17 cell balance at early preg-
nancy. This report supports our prior evidence of a
virus-induced, pro-inflammatory placental microenvir-
onment at early pregnancy.
Methods
Animals and virus
Cats (Felis domesticus) were specific pathogen free (SPF),
reproductively-mature female animals purchased at age
less than 12 months. The animals were obtained from a
commercial cattery (Liberty Research, Inc.). Ten cats
were inoculated intravenously with 1 cc a feline plasma
pool containing FIV-B-2542 at approximately 1×104 cop-
ies per ml; ten cats were uninoculated controls. Whole
blood (15 ml) was collected into VacutainerW tubes at bi-
weekly to monthly intervals until delivery of kittens.
Serum, plasma, and peripheral blood leukocytes (PBLs)
were collected. Confirmation of infection was performed
by standard PCR and serology [18]. Queens were allowed
to breed naturally with SPF males. Fetuses were delivered
by cesarean section immediately after pregnancies were
confirmed by ultrasonography at week 3–4 gestation
(early term) or at 8 weeks gestation (late term). The time
of FIV inoculation to delivery ranged from approximately
9.5 to 13.5 months (mean 11.14 months) for the early-
gestation study and 4.7 to 14.1 months (mean
9.5 months) for the late-gestation study. Fetal and pla-
cental tissues were collected from all animals, snap fro-
zen in liquid nitrogen, and frozen at −80°C. Infected
animals (n = 10) used were euthanized following delivery.
Control (n = 10) cats were spayed and released for adop-
tion after recovery. Animal protocols were approved by
the Institutional Animal Care and Use Committee of
Mississippi State University. Placental samples used for
confocal analysis and immunohistochemistry and qRT-
PCR analyses are shown in Tables 1 and 2 respectively.
All surgical procedures were performed under appropri-
ate anesthetic protocols. All queens were premedicated
with acepromoazine (0.05 mg/kg) and burophanol














7824A - - V 13671 AP - - V
7824B - - V 13671 DP - - V
7824 C - - V 13668 AP - - V
2779A - - V 13668 BP - - V
2779E - - V 9746 AP - - V
6108A - - V 9746 DP - - V
8291A - - V 9801 AP - - V
8291B - - V 9801 BP - - V
9784B - - V 9674 AP + + V
6062B + + V 9809 A + + V
6062 C + + V 13226 AP + + NV
8035B + + NV 13226 BP + + NV
1893B + + NV 9730 R1 + + NV
1893 C + + V 9813 R1 + + NV
1126A + + V 9813 R2 + + NV
1126D + + V
5111A + + V
5111 C + + NV
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before induction. A 50:50 mixture of diazepam (5 mg/ml)
and ketamine (100 mg/ml) was used for induction at an
intravenous dosage of 0.1-0.14 ml/kg. The cat was then
intubated and maintained under anesthesia with 1-2% iso-
flurane. Intravenous fluids were provided at a rate of
10 ml/kg/h. After collection of reproductive tissues and
blood samples, all queens were euthanized (Beuthanasia
solution 1 ml/lb IV) while under anesthesia. This method
was consistent with the recommendations of the Panel on
Euthanasia of the American Veterinary Medical Associ-
ation. Animal protocols were approved by the Institu-
tional Animal Care and Use Committee of Mississippi
State University.
Detection of virus in tissue
Placental tissues were evaluated for FIV provirus using
standard PCR or for viral RNA targeting FIV gag using
qPCR according to the published protocols [17-19].
Purification of RNA from feline placental tissues and
conversion to cDNA
Random sections of tissue were obtained from whole
placenta. TRIzol Reagent (Invitrogen, Carlsbad, CA) was
used to purify RNA from these tissues. RNA was purifiedfrom the aqueous phase as described [20]. Concentra-
tions were determined using a NanoDrop 1000 (Thermo
Scientific, Waltham, MA). Purified RNA was reverse
transcribed using High Capacity cDNA kit (Applied Bio-
systems). Reverse transcription reactions (20ul) were per-
formed using the following protocol: 25°C for 10 min,
37°C for 120 min, 85°C for 5 sec.
Quantification of cytokines and Treg markers by real time
PCR
Complementary DNA obtained from the High Capacity
cDNA reactions were used in gene expression analysis.
Primetime assays (Integrated DNA Technologies, Coral-
ville, Iowa) were used to evaluate the expression levels
of IL-6 and TGF-β, along with the housekeeping gene β-
actin. The primer/probe combination for use in real
time analysis of TGF-β (GenBank accession number
AY425617) was as follows: probe (/56-FAM/AGC AAT
AAT/ZEN/TCC TGG CGC TAC CTC AGC A/
3IABkFQ/), forward primer (AGC ACG TGG AGC
TGT ACC AGA AAT), and reverse primer (TCC AGT
GAC ATC AAA GGA CAG CCA). Primer/probe com-
binations used for IL-6 and β-actin were previously
described [21]. Probes for target genes were labeled at
the 5’ and 3’ ends with 6-carboxyfluorescein (FAM) and
Table 2 Placental samples included in Treg expression
analyses





8059A - - V
8059B - - V
8059 C - - V
8059D - - V
6108A - - V
6108B - - V
6108 C - - V
7824A - - V
7824B - - V
7824 C - - V
6062A + + V
6062B + + V
8035A + + V
8035 C + + NV
1126A + + V
1126B + + V
5111B + + V
5111 C + + NV
0866A + + V
0866B + + NV
V= viable fetus.
NV= non-viable fetus.
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performed with a target gene and the housekeeping gene
using an ABI thermocycler (Applied Biosystems, Carls-
bad, CA) with the following protocol: Step 1- 50°C,
2 min and 95°C, 10 min; Step 2–40 cycles (95°C for
15 sec and 60°C for 1 min.) [16] . Each reaction well
contained 10ul of the 2X Taqman gene expression
master mix, 1ul of 20X TaqMan gene expression
assay and approximately 6ug of cDNA. For every pla-
cental RNA sample, parallel reactions were run in
duplicate on separate plates for each gene. Serially-
diluted, pooled RNA from control cats was used to
generate a standard curve for simplex reactions.
Standard curves were used to calculate the correction
coefficient for each target. Differences in the amount
of template cDNA in each reaction were corrected by
the cycle threshold (Ct) value for β-actin. Compari-
sons of Treg markers between infected versus unin-
fected placentas were analyzed statistically using
ANOVA. Correlation analyses were done using simple
regression analyses (http://asuc.org/index.php/student-
resources/mentorship-program). Differences were
considered significant at p ≤ 0.05.Localization of Tregs and Th17 cells in placental tissues
using immunohistochemistry (IHC)
An IHC protocol developed by our laboratory for de-
tection of specific cell populations in frozen feline
placental sections [22] was used to localize Treg and
Th17 cells. Rabbit polyclonal antibodies (Abcam,
Cambridge, MA,1:500) to FoxP3 and RORγ were used
to identify Treg and Th17 cells, respectively. The ma-
ternal-fetal interface was determined using a rabbit
polyclonal antibody to porcine relaxin (1:500) (a gift
from Dr. Peter Ryan, Mississippi State University De-
partment of Animal and Dairy Sciences) [23,24]. Par-
allel sections were stained sequentially for relaxin,
FoxP3, RORγ, and a universal negative control. Tis-
sues were incubated with ready to use secondary
antibody, goat anti-rabbit IgG, poly-horseradish per-
oxidase (HRP) (Chemicon International Inc., Teme-
cula, CA.) and developed with 3,3’-diaminobenzidine
(DAB, Invitrogen). Tissues were counterstained with
Mayer hematoxylin and dehydrated.
Immunofluorescence staining
Snap frozen placental tissues were embedded in OCT
(Tissue-TekW, Sakura Finetek, Torrance, CA.) and sec-
tioned to a thickness of 4um using a cryostat. Five ran-
dom sections for each placenta collected from the
maternal/fetal interface were placed on poly-L-lysine
coated slides and allowed to dry. Tissues were fixed in
acetone (100%) for 15 minutes at room temperature
and then treated with 0.01% Triton-X-100 to
permeabilize the tissue. Sections were blocked with fe-
line IgG (0.1 mg/ul) and 5% non-fat milk, and incu-
bated at 4°C for at least 1 hour. Sections were
incubated with either rabbit polyclonal antibody to
RORγ (Abcam, Cambridge, MA; dilution 1:500) or
rabbit polyclonal antibody to FoxP3 (Abcam, Cam-
bridge, MA; dilution 1:500) for 2 h at 4°C. Secondary
antibody, goat anti-rabbit IgG (H + L) fluorescein con-
jugated (CHEMICON, Temecula, CA, 1:500), was ap-
plied and incubated 45 minutes to 1 h at 4°C. Parallel
sections were treated with isotype-matched control
antibodies (Dako North America Inc., Carpinteria CA.)
conjugated with appropriate fluorochromes to assure
that reactivity was not a result of non-specific binding.
Sections were mounted with Vecta shield containing
DAPI (Vector Laboratories, Inc.).
Confocal microscopy
The fluorescence intensity was acquired using a Zeiss
LSM 510 confocal laser scanning microscope (Carl Zeiss
Microimaging, Inc, Thornwood, NY) with an inverted
Zeiss Axiovert 200 M light microscope and a plan apo-
chromat 40 X/1.30 NA objective lens. A DAPI/fluores-
cein filter set was used in single channel mode imaging.
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and Band Pass (BP) Emission wavelengths of 420–
480 nm (Blue) and Long Pass (LP) 505 nm (Green) were
acquired at 1024 × 1024 pixel format for imaging pur-
poses. Fluorescence intensity was collected from 10 ran-
domly selected fields of view per section. A ratio of
FoxP3 or RORγ intensity versus DAPI intensity was cal-
culated to quantify the number of stained cells/total
cells. Background fluorescence was acquired for each
sample using the secondary antibody.
Statistical analyses
Statistical analyses of mean fluorescence intensity for tar-
geted cell populations (FoxP3 and RORγ) between FIV
control and infected cats were done using ANOVA or Wil-
coxon two-independent sample T test. Simple regression
analysis (http://www.socr.ucla.edu/htmls/SOCR_Analyses.
html) was used to determine correlations. Differences were
considered significant at p≤ 0.05.
Results
FIV infection status of placental tissues
All inoculated animals became infected with FIV [18,19],
and FIV provirus or viral RNA was detected in all pla-
cental tissues tested [17]. Fetal outcome in early [19] and
late-term [18] pregnancies was reported previously; non-
viability was significantly higher in FIV-infected queens
at both stages of pregnancy. Placental samples and infec-
tion status are listed in Tables 1 and 2. Table 1 identifiesFigure 1 Immunohistochemical localization of relaxin, FoxP3, and R
term placental sample. Relaxin localized in the placental trophoblast at
at the maternal-fetal interface (arrows) (b,c). A universal negative contro
magnification).placental samples from early and late term gestation
included in the confocal analyses used to quantify RORγ
and FoxP3 in the infected and control groups. Table 2
identifies placental samples from early term gestation
included in the Treg expression analyses.
Localization of Tregs and Th17 cells at the maternal-fetal
interface
Tregs and Th17 cells were localized by comparing parallel
tissue sections immunolabeled for relaxin (Figure 1a),
FoxP3 (Figure 1b), and RORγ (Figure 1c). A specimen trea-
ted with the universal negative control reagent (Figure 1d)
did not label, showing that non-specific binding of the sec-
ondary antibody did not occur.
Quantification of RORγ and FoxP3 staining in FIV-infected
and control cats
Immunofluorescence-labeling of FoxP3 and RORγ
expressing cells, Treg and Th17 cells, respectively, at the
maternal-fetal interface is shown in representative FIV
infected samples (Figure 2). Negative control reactions
(Figure 2, top panel) showed minimal background fluor-
escence, validating the specificity of the primary anti-
bodies. Reactivity to FoxP3 or RORγ is shown (middle
panel). The intranuclear expression of FoxP3 and RORγ
was evident when labeled cells were stained with DAPI
(bottom panel).
The cell populations were quantified by measuring
the mean fluorescence intensity of the respective cellORγ at the maternal-fetal interface of a representative early
the maternal-fetal interface (arrow) (a). FoxP3 and RORγ co-localized
l was included to assure no nonspecific binding occurred (d). (20X
Figure 2 Immunofluorescence labeling of RORγ and FoxP3 at
the maternal fetal interface of tissue from representative
infected cat. Negative controls included no primary antibody
(top panels). RORγ and FoxP3 (green) were detected using
polyclonal rabbit anti-FoxP3 or anti-RORγ antiserum followed by
goat anti-rabbit IgG (H + L) fluorescein conjugate (middle panels).
Cells were counterstained with DAPI (blue) (bottom panels). Cells
were viewed by confocal laser scanning microscopy using a 40x oil
immersion objective.
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the detection of RORγ, there was no significant differ-
ence in the Th17 population between infected and con-
trol groups at early gestation (p = 0.417) (Figure 3a).
However, the FoxP3 measurement was significantly
lower in the infected than the control group (p = 0.043),
suggesting a decreased population of Treg cells in pla-
centas from infected animals. FoxP3 and RORγ expres-
sion positively correlated in FIV-positive cats at early
gestation (p = 0.008). However, the two markers were
independent in control animals (p = 1.00), (Figure 4 a
and b). We detected no significant differences between
specimens collected from viable and non-viable placen-
tas. Therefore, those comparisons are not presented
separately.
Expression of IL-6 and TGF-β in placental tissues
Differences in the expression of IL-6 and TGF-β were
determined using the comparative Ct method with mean
values for each cytokine from the controls used as the
references. The fold change for IL-6 from infected animalswas 3.05, while that from control animals was 1.93. How-
ever, perhaps due to large variation in this small sample
size, the data did not reach the level of significance
(p= 0.444). TGF-β expression was significantly reduced
(p= 0.007) in infected tissues (fold change= 0.477) as
compared to control samples (fold change= 1.23)
(Figure 5a). Co-expression of the two cytokines was sub-
jected to correlation analysis. Control animals exhibited a
highly significant positive correlation in the expression of
the two cytokines (P= 7.0 × 10-7) (Figure 5b), while
infected animals were neither positively nor negatively
correlated (Figure 5c). We detected no significant differ-
ences between specimens collected from viable and non-
viable placentas. Therefore, those comparisons are not
presented separately.
Conclusion
Tregs accumulate in the human decidua during early,
normal pregnancy, while Th17 cells are depressed at
this stage. The ratio of these cells is reversed as partur-
ition approaches, allowing the inflammatory environ-
ment that promotes the onset of labor and expulsion
of the fetus [3]. Likewise, Th17 cells often dominate in
cases of failed pregnancy or placental infection [12,25],
illustrating the importance of the balance in these cell
populations to pregnancy outcome. The data concern-
ing a role for Tregs and Th17 cells in the feline pla-
centa is extremely limited. Thus, it was important to
confirm the presence of both populations and the loca-
tion of these cells within the tissue. We did so by com-
paring parallel sections immunolabeled for expression
of FoxP3 and RORγ protein to sections labeled for re-
laxin. Relaxin is a protein hormone produced by decid-
ual cells that causes cervical ripening, pelvic elasticity,
and induction of labor late in human pregnancy, in
part by inducing the expression of key inflammatory
cytokines from decidual cells [26]. In the cat, relaxin is
known to be expressed by trophoblasts [27]. Thus, ex-
pression of relaxin can be used to demarcate the ma-
ternal-fetal interface. We found that Tregs and Th17
cells co-localize at the maternal-fetal interface in the
cat.
In this study, we used placental tissues from FIV-infected
and control queens to begin to evaluate how these cell
populations may be involved in lentivirus-induced placen-
tal inflammation in the cat model. In previous studies we
reported a pro-inflammatory placental environment and
high levels of reproductive failure in the FIV-infected cat
model of mother-to-child transmission of lentiviruses [17].
We found evidence of virus-associated depression of the
Treg population at early pregnancy by qPCR analysis of
expression of FoxP3 mRNA [17]. In the present study,
FoxP3 protein was likewise depressed in the infected
group, providing additional evidence of Treg depletion. On
Figure 3 Quantification of RORγ and FoxP3 staining in FIV infected and control cats. Mean fluorescence intensity of FoxP3 and RORγ, which
label Treg and Th17 cells, respectively, were measured in both control and infected cats. Values are bracketed by standard error of the mean.
Control (n = 9) versus infected (n = 11) samples were evaluated. P values< 0.05 were considered significant.
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controls animals, suggesting no viral effect on this T cell
population.
Treg and Th17 cell populations are normally negatively
correlated with reciprocal pathways for immunosuppression
or inflammation [28,29]. TGF-β and IL-6 facilitate the
proliferation of Tregs and Th17 cells by activating their
intranuclear transcription factors FoxP3 and RORγ, re-
spectively. Although we predicted a negative correlation
between FoxP3 and RORγ in control tissues given theirusual reciprocal relationship in the periphery, expres-
sion of the two markers was independent in the control,
correlating neither positively nor negatively. However,
we detected a significant positive correlation of FoxP3
and RORγ co-expression at early pregnancy in the
infected group. Given the role of these T cell popula-
tions during maintenance of pregnancy, we suspect that
an imbalance of Treg and Th17 cells contributes to the
fetal demise in FIV-infected cats at early pregnancy that
we reported previously [19].
Figure 4 Correlation of expression of FoxP3 and RORγ. Correlation of FoxP3 to RORγ in infected (a) and control (b) cats at early gestation.
Analysis was performed using a simple regression analysis. P values <0.05 were considered significant.
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production of TGF-β, an anti-inflammatory cytokine,
by the Treg population. TGF-β normally drives the dif-
ferentiation of both Tregs and Th17 cells from progeni-
tor CD4+ T cells. Generation of Th17 cells requires the
additional presence of IL-6 and IL-21 [30]. In this
study, we found that FIV infection alters cytokine ex-
pression in the placenta. A significant decrease in
TGF-β in placentas from the infected group was
detected, possibly explaining the decrease in the pla-
cental Treg population in infected cats at early preg-
nancy that we reported here and previously [17].
However, Th17 cells are likewise dependent upon TGF-
β to initiate their differentiation from progenitor T
cells. We found significantly increased levels of IL-6
expression in early-term placentas in an earlier study
[16]. Measuring fold change in IL-6 expression be-
tween control and infected tissues in the present study,
the increase in IL-6 that was noted in infected tissues
did not reach the level of significance due to large vari-
ation in this small sample size. This finding is consist-
ent with the unchanged RORγ expression that we
detected between the two groups. The detection of apositive correlation between the two cytokines in con-
trol animals while no significant correlation occurred
in infected animals supports a virus-induced disruption
in the normal balance between these two cytokines.
Collectively, the data provide evidence that altered ex-
pression of key cytokines accompanies virus infection,
likely contributing to the Treg/Th17 imbalance that
occurs in infected animals.
This report provides additional evidence that FIV
infection reduces the Treg population at the mater-
nal-fetal interface in the cat model while leaving the
Th17 population unchanged. This imbalance in the
normal ratio of these cell populations would likely
predispose a pro-inflammatory placental environment
that would promote the excessive reproductive failure
that we previously reported in this group of animals
[19]. Currently, immunomodulator profiles from laser
capture microdissected Treg and Th17 cells and ad-
jacent placental microenvironments are being evalu-
ated in the FIV-infected cat model. These profiles
may illuminate the functional effects of viral infec-
tion on these immunologically-important placental
cell populations.
Figure 5 Expression of IL-6 and TGF-β in placental tissues. Fold change for IL-6 and TGF-β were calculated in control versus infected animals
(a). The expression of IL-6 and TGF-β were correlated in control (b) (n = 10) and infected (c) (n = 10) placental tissues at early gestation. The data
were analyzed using an ANOVA (A) or simple regression analysis (B,C). P values <0.05 were considered significant.
Boudreaux et al. Virology Journal 2012, 1:88 Page 9 of 10
http://www.virologyj.com/content/1/9/88
Boudreaux et al. Virology Journal 2012, 1:88 Page 10 of 10
http://www.virologyj.com/content/1/9/88Competing interests
The authors declare they have no competing interests.
Acknowledgements
We express gratitude to Dr. Bridget Willeford and Jamie Allison for veterinary
assistance. We thank Bill Monroe for assistance with confocal microscopy, Dr.
Mark Welch for use of his ABI thermocycler, Dr. Peter Ryan for his generous
gift of the relaxin antibody, and Dr. Sarah McDonald for her suggestions on
this manuscript. This project was supported by the National Institutes of
Health project # 1R21AI088187-01A1 and # 2R15AI048410-02A1.
Authors’ contributions
CEB conducted all experiments, analyzed data, and wrote the manuscript.
LBC assisted with tissue sectioning. VLS provided instruction and some
analysis with qPCR. DAW provided advice regarding confocal microscopy
and data interpretation. KSC secured funding, supervised the project, assisted
with data interpretation, and edited the manuscript. All authors read and
approved the final manuscript.
Received: 16 December 2011 Accepted: 4 May 2012
Published: 4 May 2012
References
1. Kwak-Kim J, Park JC, Ahn HK, Kim JW, Gilman-Sachs A: Immunological
modes of pregnancy loss. Am J Reprod Immunol 2010, 63:611–623.
2. Mellor AL, Munn DH: Immunology at the maternal-fetal interface: lessons
for T cell tolerance and suppression. Annu Rev Immunol 2000, 18:367–391.
3. Guerin LR, Prins JR, Robertson SA: Regulatory T-cells and immune
tolerance in pregnancy: a new target for infertility treatment? Hum
Reprod Update 2009, 15:517–535.
4. Saito S, Nakashima A, Shima T, Ito M: Th1/Th2/Th17 and regulatory T-cell
paradigm in pregnancy. Am J Reprod Immunol 2010, 63:601–610.
5. Munoz-Suano A, Hamilton AB, Betz AG: Gimme shelter: the immune
system during pregnancy. Immunol Rev 2011, 241:20–38.
6. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO,
Hatton RD, Wahl SM, Schoeb TR, Weaver CT: Transforming growth factor-
beta induces development of the T(H)17 lineage. Nature 2006, 441:231–
234.
7. Li MO, Wan YY, Flavell RA: T cell-produced transforming growth
factor-beta1 controls T cell tolerance and regulates Th1- and Th17-
cell differentiation. Immunity 2007, 26:579–591.
8. Bettelli E, Korn T, Kuchroo VK: Th17: the third member of the effector T
cell trilogy. Curr Opin Immunol 2007, 19:652–657.
9. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S: Decidual and
peripheral blood CD4+ CD25+ regulatory T cells in early pregnancy
subjects and spontaneous abortion cases. Mol Hum Reprod 2004, 10:347–
353.
10. Winger EE, Reed JL: Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory
cell levels predict miscarriage risk in newly pregnant women with a
history of failure. Am J Reprod Immunol 2011, 66:320–328.
11. Zhu XY, Zhou YH, Wang MY, Jin LP, Yuan MM, Li DJ: Blockade of CD86
signaling facilitates a Th2 bias at the maternal-fetal interface and
expands peripheral CD4 +CD25+ regulatory T cells to rescue abortion-
prone fetuses. Biol Reprod 2005, 72:338–345.
12. Liu YS, Wu L, Tong XH, Wu LM, He GP, Zhou GX, Luo LH, Luan HB: Study on
the relationship between Th17 cells and unexplained recurrent
spontaneous abortion. Am J Reprod Immunol 2011, 65:503–511.
13. Langston C, Lewis DE, Hammill HA, Popek EJ, Kozinetz CA, Kline MW,
Hanson IC, Shearer WT: Excess intrauterine fetal demise associated with
maternal human immunodeficiency virus infection. J Infect Dis 1995,
172:1451–1460.
14. D'Ubaldo C, Pezzotti P, Rezza G, Branca M, Ippolito G: Association between
HIV-1 infection and miscarriage: a retrospective study. DIANAIDS
Collaborative Study Group. Diagnosi Iniziale Anomalie Neoplastiche
AIDS. AIDS 1998, 12:1087–1093.
15. Kumar SB, Rice CE, Milner DA Jr, Ramirez NC, Ackerman WEt, Mwapasa V,
Turner AN, Kwiek JJ: Elevated cytokine and chemokine levels in the
placenta are associated with in-utero HIV-1 mother-to-child transmission.
AIDS 2012, 26:685–694.
16. Scott VL, Boudreaux CE, Lockett NN, Clay BT, Coats KS: Cytokine
dysregulation in early- and late-term placentas from felineimmunodeficiency virus (FIV)-infected cats. Am J Reprod Immunol 2011,
65:480–491.
17. Lockett NN, Scott VL, Boudreaux CE, Clay BT, Pruett SB, Ryan PL, Coats KS:
Expression of regulatory T cell (Treg) activation markers in endometrial
tissues from early and late pregnancy in the feline immunodeficiency
virus (FIV)-infected cat. Placenta 2010, 31:796–802.
18. Weaver CC, Burgess SC, Nelson PD, Wilkinson M, Ryan PL, Nail CA, Kelly-
Quagliana KA, May ML, Reeves RK, Boyle CR, Coats KS: Placental
immunopathology and pregnancy failure in the FIV-infected cat. Placenta
2005, 26:138–147.
19. Boudreaux CE, Lockett NN, Chemerys DN, Clay BT, Scott VL, Willeford B,
Brown T, Coats KS: Maternal hematological and virological characteristics
during early feline immunodeficiency virus (FIV) infection of cats as
predictors of fetal infection and reproductive outcome at early gestation.
Vet Immunol Immunopathol 2009, 131:290–297.
20. Scott VL, Burgess SC, Shack LA, Lockett NN, Coats KS: Expression of CD134
and CXCR4 mRNA in term placentas from FIV-infected and control cats.
Vet Immunol Immunopathol 2008, 123:90–96.
21. Scott VL, Shack LA, Eells JB, Ryan PL, Donaldson JR, Coats KS:
Immunomodulator expression in trophoblasts from the feline
immunodeficiency virus (FIV)-infected cat. Virol J 2011, 8:336.
22. Scott VL, Wallace K, Mays S, Ryan P, Coats KS: An immunohistochemical
assay to detect trophoblasts in frozen feline placenta. J Vet Diagn Invest
2011, 23:275–281.
23. Porter DG, Ryan PL, Norman L: Lack of effect of relaxin on oxytocin output
from the porcine neural lobe in vitro or in lactating sows in vivo. J
Reprod Fertil 1992, 96:251–260.
24. Porter DG, Friendship RM, Ryan PL, Wasnidge C: Relaxin is not associated
with poor milk yield in the postpartum sow. Can J Vet Res 1992, 56:204–
207.
25. Zhang H, Hu X, Liu X, Zhang R, Fu Q, Xu X: The Treg/Th17 imbalance in
Toxoplasma gondii-infected pregnant mice. Am J Reprod Immunol 2012,
67:112–121.
26. Bryant-Greenwood GD, Kern A, Yamamoto SY, Sadowsky DW, Novy MJ:
Relaxin and the human fetal membranes. Reprod Sci 2007, 14:42–45.
27. Klonisch T, Mathias S, Cambridge G, Hombach-Klonisch S, Ryan PL, Allen WR:
Placental localization of relaxin in the pregnant mare. Placenta 1997,
18:121–128.
28. Xu L, Kitani A, Fuss I, Strober W: Cutting edge: regulatory T cells induce
CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in
the absence of exogenous TGF-beta. J Immunol 2007, 178:6725–6729.
29. Zheng SG, Wang J, Horwitz DA: Cutting edge: Foxp3+CD4+CD25+
regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17
conversion by IL-6. J Immunol 2008, 180:7112–7116.
30. Deenick EK, Tangye SG: Autoimmunity: IL-21: a new player in Th17-cell
differentiation. Immunol Cell Biol 2007, 85:503–505.
doi:10.1186/1743-422X-9-88
Cite this article as: Boudreaux et al.: Imbalance of placental regulatory T
cell and Th17 cell population dynamics in the FIV-infected pregnant cat.
Virology Journal 2012 1:88.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
